Cargando…
Can the New and Old Drugs Exert an Immunomodulatory Effect in Acute Myeloid Leukemia?
SIMPLE SUMMARY: The advent of novel immunotherapeutic strategies has revealed the importance of immune dysregulation and of a tolerogenic microenvironment for acute myeloid leukemia (AML) fitness. We reviewed the “off-target” effects on the immune system of different drugs used in the treatment of A...
Autores principales: | Tarantini, Francesco, Cumbo, Cosimo, Anelli, Luisa, Zagaria, Antonella, Specchia, Giorgina, Musto, Pellegrino, Albano, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393879/ https://www.ncbi.nlm.nih.gov/pubmed/34439275 http://dx.doi.org/10.3390/cancers13164121 |
Ejemplares similares
-
Inside the biology of early T-cell precursor acute lymphoblastic leukemia: the perfect trick
por: Tarantini, Francesco, et al.
Publicado: (2021) -
Second Cancer Onset in Myeloproliferative Neoplasms: What, When, Why?
por: Cumbo, Cosimo, et al.
Publicado: (2022) -
A Crumbled but Fatal Acute Leukemia
por: Tarantini, Francesco, et al.
Publicado: (2022) -
Exploring the Potential of Eltrombopag: Room for More?
por: Tarantini, Francesco, et al.
Publicado: (2022) -
Monitoring of Minimal Residual Disease (MRD) in Chronic Myeloid Leukemia: Recent Advances
por: Cumbo, Cosimo, et al.
Publicado: (2020)